Tandem Diabetes Care Reports Positive Results From Two Studies ...

Time spent with glucose values above 180 mg/dL was reduced from 36 percent to 25 percent (p<0.001), and time spent below 70 mg/dL was reduced ...

Press Releases | Tandem Diabetes Care - Investor Relations

Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology. Significant Time-in-Range ...

Tandem Diabetes Posts Positive Data on t:slim X2 With Basal-IQ

TNDM recently announced positive study results of the t: slim X2 insulin pump with Basal-IQ predictive low-glucose suspend technology. The ...

Real-World Patient-Reported Outcomes and Glycemic Results with ...

Tandem's t:slim X2 insulin pump with Control-IQ technology offers a significant advancement in diabetes care. A 6-month randomized, controlled ...

Tandem Diabetes Care Announces Control-IQ Technology Meta ...

Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on ...

Tandem Diabetes Care Announces Third Quarter 2024 Financial ...

“The third quarter marked a milestone achievement for Tandem Diabetes Care as we delivered the highest quarterly sales in our Company's history, ...

Tandem Mobi Improves Quality of Life for People Living With Type 1 ...

SAN DIEGO --(BUSINESS WIRE)--Jun. 22, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology ...

Tandem Diabetes Care Presents Positive Real-world Data from ...

This poster reported outcomes from a retrospective analysis of users who uploaded at least 30 days of data to the t:connect® web application ...

News Release - Investor Relations - Tandem Diabetes

Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the ...

Tandem Diabetes Care Announces Publication of PROLOG Study ...

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2018-- Tandem Diabetes Care®, Inc. ... The study demonstrated that the t:slim X2 Pump with Basal-IQ ...

Tandem Diabetes Care Study Demonstrates Improvements of All ...

(NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced results from a prospective, multicenter, single-arm study ...

Effect of Verapamil on Pancreatic Beta Cell Function in Newly ...

Dr Van Name reported receiving research support from ProventionBio. Dr Kollman reported receiving grants from Dexcom and Tandem Diabetes Care.

Tandem Diabetes Care Announces NEJM Publication of Study ...

... results reported in the study and the level of customer satisfaction from the use of our products and features may be different from what we ...

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in ...

Funding was provided by the National Institute of Diabetes and Digestive and Kidney Diseases. Tandem Diabetes Care provided the experimental ...

Validation of Time in Range as an Outcome Measure for Diabetes ...

The hazard rate of development of retinopathy progression was increased by 64% (95% CI 51–78), and development of the microalbuminuria outcome ...

Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin ...

In the prospective clinical study by Mingorance Delgado et al. [26], the same survey improved parents' subjective feelings about diabetes ...

Study backs Tandem Control-IQ artificial pancreas in young children

Tandem Diabetes Care (Nasdaq:TNDM) announced positive study data for its artificial pancreas using Control-IQ technology.

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a ...

... two key ingredients for a likely earnings beat in its upcoming report ... reports results for the quarter ended September 2024. This widely ...

Tandem Diabetes Care, Inc. - Patsnap Synapse

01) indicating reduced burden of diabetes on daily life. These findings were noted regardless of patients' baseline insulin delivery methods (MDI or insulin ...

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed ...

The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic improvements in large randomized controlled and real-world trials. Use of this system ...